1. Home
  2. ESQ vs AKBA Comparison

ESQ vs AKBA Comparison

Compare ESQ & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESQ
  • AKBA
  • Stock Information
  • Founded
  • ESQ 2006
  • AKBA 2007
  • Country
  • ESQ United States
  • AKBA United States
  • Employees
  • ESQ 138
  • AKBA N/A
  • Industry
  • ESQ Commercial Banks
  • AKBA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ESQ Finance
  • AKBA Health Care
  • Exchange
  • ESQ Nasdaq
  • AKBA Nasdaq
  • Market Cap
  • ESQ 858.2M
  • AKBA 729.1M
  • IPO Year
  • ESQ 2017
  • AKBA 2014
  • Fundamental
  • Price
  • ESQ $98.96
  • AKBA $1.57
  • Analyst Decision
  • ESQ Hold
  • AKBA Strong Buy
  • Analyst Count
  • ESQ 3
  • AKBA 6
  • Target Price
  • ESQ $113.00
  • AKBA $6.25
  • AVG Volume (30 Days)
  • ESQ 69.8K
  • AKBA 6.9M
  • Earning Date
  • ESQ 10-23-2025
  • AKBA 11-10-2025
  • Dividend Yield
  • ESQ 0.70%
  • AKBA N/A
  • EPS Growth
  • ESQ 14.70
  • AKBA N/A
  • EPS
  • ESQ 5.68
  • AKBA N/A
  • Revenue
  • ESQ $131,743,000.00
  • AKBA $225,071,000.00
  • Revenue This Year
  • ESQ N/A
  • AKBA $53.38
  • Revenue Next Year
  • ESQ $26.30
  • AKBA $30.53
  • P/E Ratio
  • ESQ $17.64
  • AKBA N/A
  • Revenue Growth
  • ESQ 13.37
  • AKBA 32.49
  • 52 Week Low
  • ESQ $68.90
  • AKBA $1.49
  • 52 Week High
  • ESQ $107.25
  • AKBA $4.08
  • Technical
  • Relative Strength Index (RSI)
  • ESQ 54.43
  • AKBA 30.67
  • Support Level
  • ESQ $95.43
  • AKBA $1.49
  • Resistance Level
  • ESQ $100.35
  • AKBA $1.84
  • Average True Range (ATR)
  • ESQ 2.79
  • AKBA 0.12
  • MACD
  • ESQ 0.44
  • AKBA -0.01
  • Stochastic Oscillator
  • ESQ 93.17
  • AKBA 14.06

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a financial holding company. Through its subsidiary, the company operates as a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. In addition, it operates a payment processing platform through third-party independent sales organizations.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Share on Social Networks: